The start of the Phase II trial has started.
Quote:
|
The multicenter, double blind, placebo controlled dose ranging study will evaluate the safety, tolerability and efficacy of AT-1001 in 79 Celiac Disease subjects during gluten challenge.
|
http://www.albatherapeutics.com/abou....html#09212006
This says they are still recruiting people for this study.
http://www.clinicaltrials.gov/ct/sho...362856?order=2
Hmmm - where are the blood tests? What are they looking for in the urine?
Quote:
|
A second purpose is to study how your body responds to the drug when you injest gluten. This response is determined by testing your urine, and by capturing your daily and weekly gastrointestinal symptoms associated with celiac disease.
|
I know this was posted on the OBT but here is an animation of "tight junction dysfunction" (Karen, where are you)
http://www.albatherapeutics.com/scie...ogy/index.html
Anne